Key facts
- This page summarizes Roger Jeffs's Form 4 filing for ALBIREO PHARMA, INC..
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 28 Jun 2021, 16:05.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
This option will vest and become exercisable in full on the earlier of (i) June 24, 2022 or (ii) the day prior to the issuer's 2022 annual meeting of stockholders, subject to the director's continued service on the issuer's board of directors on the vesting date.